Pfizer Inc announced the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities starting with sickle cell disease (SCD). The acquisition reinforces Pfizer’s commitment to SCD, building on a 30-year legacy in the rare hematology space.
- Read more about Pfizer Completes Acquisition of Global Blood Therapeutics
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/pfizer-completes-acquisition-of-global-blood-therapeutics
No comments:
Post a Comment